You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
潤達醫療(603108.SH)上半年扣非歸母淨利增24.23%至1.79億元
格隆匯 08-22 16:09

格隆匯8月22日丨潤達醫療(603108.SH)公佈2019上半年業績,公司實現營收32.95億元,同比增長17.88%;歸屬於上市公司股東的淨利潤1.75億元,同比增長20.97%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.79億元,同比增長24.23%。

公司在2019年上半年依然專注於醫學實驗室綜合服務業務,持續整體綜合服務業務的推廣,優化服務內容,強化人力資源建設,加強擴張區域的業務整合力度,在2019年上半年取得了穩中有升的經營業績,保持了良好的發展勢頭。

公司在主營業務進一步廣拓深耕,積極拓展市場,繼續推進整體綜合服務業務,市場接受度逐步提高,公司不斷提升增值服務的內容和品質加強核心競爭力。

2017年度公司已基本完成市場戰略佈局,2018年至今公司進一步落實渠道擴容,將業務範圍快速覆蓋到華東、華北、東北、華中、西南地區,尤其華中、西南地區的收入增速超過公司整體增長水平。業務規模、經營形態、市場佔有率等方面獲得較大提升。

在分級診療、兩票制的政策指導下,公司不斷探索圍繞整體綜合服務業務的配套業務模式,在整體綜合服務業務較成規模的上海及黑龍江地區開展第三方精準檢測實驗室業務,在哈爾濱地區實行了108家醫院實驗室檢驗結果互認的信息系統搭建工程,同時在全國範圍內支持28家醫院成立區域檢驗中心並提供整體綜合服務,進一步擴大公司業務規模。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account